Alvotech(ALVO) - 2023 Q1 - Quarterly Report

Exhibit 99.1 REYKJAVIK, ICELAND (March 1, 2023) — Alvotech (NASDAQ: ALVO, or the "Company"), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported financial results for full year 2022 and provided a summary of recent corporate highlights. "Alvotech made significant progress in 2022. We were publicly listed, achieved a remarkable 114% increase in revenue, and were able to continue investing in and shaping our future through the ...